nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—Hepatomegaly—Entecavir—hepatitis B	0.0289	0.033	CcSEcCtD
Triamcinolone—Myopathy—Adefovir Dipivoxil—hepatitis B	0.0285	0.0325	CcSEcCtD
Triamcinolone—Glycosuria—Entecavir—hepatitis B	0.0253	0.0288	CcSEcCtD
Triamcinolone—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.0247	0.0281	CcSEcCtD
Triamcinolone—Myopathy—Telbivudine—hepatitis B	0.024	0.0274	CcSEcCtD
Triamcinolone—Hepatomegaly—Telbivudine—hepatitis B	0.0238	0.0271	CcSEcCtD
Triamcinolone—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0218	0.0249	CcSEcCtD
Triamcinolone—SERPINA6—blood plasma—hepatitis B	0.0187	0.229	CbGeAlD
Triamcinolone—Anaphylactoid reaction—Entecavir—hepatitis B	0.0154	0.0175	CcSEcCtD
Triamcinolone—Folliculitis—Lamivudine—hepatitis B	0.0151	0.0172	CcSEcCtD
Triamcinolone—Myopathy—Lamivudine—hepatitis B	0.0135	0.0154	CcSEcCtD
Triamcinolone—Hepatomegaly—Lamivudine—hepatitis B	0.0134	0.0153	CcSEcCtD
Triamcinolone—Throat sore—Lamivudine—hepatitis B	0.0132	0.015	CcSEcCtD
Triamcinolone—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.013	0.0149	CcSEcCtD
Triamcinolone—Pancreatitis—Entecavir—hepatitis B	0.0126	0.0144	CcSEcCtD
Triamcinolone—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.0123	0.014	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Entecavir—hepatitis B	0.0119	0.0136	CcSEcCtD
Triamcinolone—Acne—Lamivudine—hepatitis B	0.0113	0.0129	CcSEcCtD
Triamcinolone—Muscular weakness—Telbivudine—hepatitis B	0.0108	0.0123	CcSEcCtD
Triamcinolone—Abdominal distension—Telbivudine—hepatitis B	0.0106	0.0121	CcSEcCtD
Triamcinolone—Influenza—Telbivudine—hepatitis B	0.0106	0.012	CcSEcCtD
Triamcinolone—Oropharyngeal pain—Lamivudine—hepatitis B	0.0104	0.0119	CcSEcCtD
Triamcinolone—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00996	0.0114	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00981	0.0112	CcSEcCtD
Triamcinolone—Vasculitis—Lamivudine—hepatitis B	0.00971	0.0111	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Telbivudine—hepatitis B	0.00922	0.0105	CcSEcCtD
Triamcinolone—BCHE—blood plasma—hepatitis B	0.00921	0.113	CbGeAlD
Triamcinolone—Wheezing—Lamivudine—hepatitis B	0.00921	0.0105	CcSEcCtD
Triamcinolone—Neuropathy—Lamivudine—hepatitis B	0.0089	0.0102	CcSEcCtD
Triamcinolone—Back pain—Adefovir Dipivoxil—hepatitis B	0.00845	0.00964	CcSEcCtD
Triamcinolone—Pharyngitis—Telbivudine—hepatitis B	0.00838	0.00956	CcSEcCtD
Triamcinolone—NR3C1—blood plasma—hepatitis B	0.0082	0.1	CbGeAlD
Triamcinolone—Cough—Adefovir Dipivoxil—hepatitis B	0.00762	0.00869	CcSEcCtD
Triamcinolone—Injury—Lamivudine—hepatitis B	0.00749	0.00854	CcSEcCtD
Triamcinolone—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00744	0.00848	CcSEcCtD
Triamcinolone—Anaphylactic shock—Entecavir—hepatitis B	0.00731	0.00833	CcSEcCtD
Triamcinolone—Infection—Entecavir—hepatitis B	0.00726	0.00828	CcSEcCtD
Triamcinolone—Dysgeusia—Telbivudine—hepatitis B	0.0072	0.00821	CcSEcCtD
Triamcinolone—Back pain—Telbivudine—hepatitis B	0.00711	0.00811	CcSEcCtD
Triamcinolone—PTGS2—blood plasma—hepatitis B	0.00709	0.0869	CbGeAlD
Triamcinolone—SERPINA6—blood—hepatitis B	0.00686	0.084	CbGeAlD
Triamcinolone—Ill-defined disorder—Telbivudine—hepatitis B	0.00682	0.00778	CcSEcCtD
Triamcinolone—Affect lability—Lamivudine—hepatitis B	0.00677	0.00773	CcSEcCtD
Triamcinolone—Malaise—Telbivudine—hepatitis B	0.00663	0.00756	CcSEcCtD
Triamcinolone—Insomnia—Entecavir—hepatitis B	0.00661	0.00754	CcSEcCtD
Triamcinolone—Mood swings—Lamivudine—hepatitis B	0.00652	0.00744	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00649	0.00741	CcSEcCtD
Triamcinolone—Dyspepsia—Entecavir—hepatitis B	0.00643	0.00734	CcSEcCtD
Triamcinolone—Cough—Telbivudine—hepatitis B	0.00642	0.00732	CcSEcCtD
Triamcinolone—Fatigue—Entecavir—hepatitis B	0.0063	0.00718	CcSEcCtD
Triamcinolone—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00628	0.00716	CcSEcCtD
Triamcinolone—Myalgia—Telbivudine—hepatitis B	0.00626	0.00714	CcSEcCtD
Triamcinolone—CYP3A4—blood plasma—hepatitis B	0.0062	0.0759	CbGeAlD
Triamcinolone—Discomfort—Telbivudine—hepatitis B	0.00619	0.00706	CcSEcCtD
Triamcinolone—Muscular weakness—Lamivudine—hepatitis B	0.00607	0.00692	CcSEcCtD
Triamcinolone—Abdominal distension—Lamivudine—hepatitis B	0.00599	0.00683	CcSEcCtD
Triamcinolone—Influenza—Lamivudine—hepatitis B	0.00595	0.00678	CcSEcCtD
Triamcinolone—Pancreatitis—Lamivudine—hepatitis B	0.00583	0.00665	CcSEcCtD
Triamcinolone—Sweating increased—Lamivudine—hepatitis B	0.00579	0.00661	CcSEcCtD
Triamcinolone—Body temperature increased—Entecavir—hepatitis B	0.00578	0.00659	CcSEcCtD
Triamcinolone—Bronchitis—Lamivudine—hepatitis B	0.00572	0.00652	CcSEcCtD
Triamcinolone—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00564	0.00643	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00547	0.00624	CcSEcCtD
Triamcinolone—Insomnia—Telbivudine—hepatitis B	0.00543	0.00619	CcSEcCtD
Triamcinolone—Paraesthesia—Telbivudine—hepatitis B	0.00539	0.00615	CcSEcCtD
Triamcinolone—SERPINA6—liver—hepatitis B	0.00536	0.0657	CbGeAlD
Triamcinolone—Dyspepsia—Telbivudine—hepatitis B	0.00528	0.00603	CcSEcCtD
Triamcinolone—Asthenia—Entecavir—hepatitis B	0.00524	0.00598	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Lamivudine—hepatitis B	0.0052	0.00593	CcSEcCtD
Triamcinolone—Fatigue—Telbivudine—hepatitis B	0.00517	0.0059	CcSEcCtD
Triamcinolone—Pain—Telbivudine—hepatitis B	0.00513	0.00585	CcSEcCtD
Triamcinolone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00511	0.00583	CcSEcCtD
Triamcinolone—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00504	0.00575	CcSEcCtD
Triamcinolone—Epistaxis—Lamivudine—hepatitis B	0.005	0.00571	CcSEcCtD
Triamcinolone—Feeling abnormal—Telbivudine—hepatitis B	0.00495	0.00564	CcSEcCtD
Triamcinolone—Dizziness—Entecavir—hepatitis B	0.00483	0.00551	CcSEcCtD
Triamcinolone—Rhinitis—Lamivudine—hepatitis B	0.00477	0.00544	CcSEcCtD
Triamcinolone—Body temperature increased—Telbivudine—hepatitis B	0.00474	0.00541	CcSEcCtD
Triamcinolone—Pharyngitis—Lamivudine—hepatitis B	0.00473	0.00539	CcSEcCtD
Triamcinolone—Vomiting—Entecavir—hepatitis B	0.00465	0.0053	CcSEcCtD
Triamcinolone—Rash—Entecavir—hepatitis B	0.00461	0.00525	CcSEcCtD
Triamcinolone—Dermatitis—Entecavir—hepatitis B	0.0046	0.00525	CcSEcCtD
Triamcinolone—Headache—Entecavir—hepatitis B	0.00458	0.00522	CcSEcCtD
Triamcinolone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00453	0.00517	CcSEcCtD
Triamcinolone—Rash—Adefovir Dipivoxil—hepatitis B	0.00449	0.00513	CcSEcCtD
Triamcinolone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00449	0.00512	CcSEcCtD
Triamcinolone—Headache—Adefovir Dipivoxil—hepatitis B	0.00447	0.00509	CcSEcCtD
Triamcinolone—Nausea—Entecavir—hepatitis B	0.00434	0.00495	CcSEcCtD
Triamcinolone—Asthenia—Telbivudine—hepatitis B	0.00431	0.00491	CcSEcCtD
Triamcinolone—Pruritus—Telbivudine—hepatitis B	0.00425	0.00484	CcSEcCtD
Triamcinolone—Nausea—Adefovir Dipivoxil—hepatitis B	0.00423	0.00483	CcSEcCtD
Triamcinolone—Erythema—Lamivudine—hepatitis B	0.00414	0.00473	CcSEcCtD
Triamcinolone—Dysgeusia—Lamivudine—hepatitis B	0.00406	0.00463	CcSEcCtD
Triamcinolone—Back pain—Lamivudine—hepatitis B	0.00401	0.00457	CcSEcCtD
Triamcinolone—Dizziness—Telbivudine—hepatitis B	0.00397	0.00453	CcSEcCtD
Triamcinolone—Ill-defined disorder—Lamivudine—hepatitis B	0.00385	0.00439	CcSEcCtD
Triamcinolone—Vomiting—Telbivudine—hepatitis B	0.00382	0.00435	CcSEcCtD
Triamcinolone—Angioedema—Lamivudine—hepatitis B	0.00379	0.00432	CcSEcCtD
Triamcinolone—Rash—Telbivudine—hepatitis B	0.00378	0.00432	CcSEcCtD
Triamcinolone—Dermatitis—Telbivudine—hepatitis B	0.00378	0.00431	CcSEcCtD
Triamcinolone—Headache—Telbivudine—hepatitis B	0.00376	0.00429	CcSEcCtD
Triamcinolone—Malaise—Lamivudine—hepatitis B	0.00374	0.00426	CcSEcCtD
Triamcinolone—Vertigo—Lamivudine—hepatitis B	0.00372	0.00425	CcSEcCtD
Triamcinolone—Syncope—Lamivudine—hepatitis B	0.00372	0.00424	CcSEcCtD
Triamcinolone—Loss of consciousness—Lamivudine—hepatitis B	0.00364	0.00415	CcSEcCtD
Triamcinolone—Cough—Lamivudine—hepatitis B	0.00362	0.00412	CcSEcCtD
Triamcinolone—Convulsion—Lamivudine—hepatitis B	0.00359	0.0041	CcSEcCtD
Triamcinolone—Nausea—Telbivudine—hepatitis B	0.00357	0.00407	CcSEcCtD
Triamcinolone—Myalgia—Lamivudine—hepatitis B	0.00353	0.00402	CcSEcCtD
Triamcinolone—Discomfort—Lamivudine—hepatitis B	0.00349	0.00398	CcSEcCtD
Triamcinolone—Dry mouth—Lamivudine—hepatitis B	0.00345	0.00394	CcSEcCtD
Triamcinolone—Oedema—Lamivudine—hepatitis B	0.00338	0.00386	CcSEcCtD
Triamcinolone—Anaphylactic shock—Lamivudine—hepatitis B	0.00338	0.00386	CcSEcCtD
Triamcinolone—BCHE—blood—hepatitis B	0.00337	0.0413	CbGeAlD
Triamcinolone—Infection—Lamivudine—hepatitis B	0.00336	0.00383	CcSEcCtD
Triamcinolone—Shock—Lamivudine—hepatitis B	0.00333	0.0038	CcSEcCtD
Triamcinolone—Hyperhidrosis—Lamivudine—hepatitis B	0.00327	0.00373	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00308	0.00351	CcSEcCtD
Triamcinolone—Insomnia—Lamivudine—hepatitis B	0.00306	0.00349	CcSEcCtD
Triamcinolone—Paraesthesia—Lamivudine—hepatitis B	0.00304	0.00346	CcSEcCtD
Triamcinolone—Dyspnoea—Lamivudine—hepatitis B	0.00302	0.00344	CcSEcCtD
Triamcinolone—NR3C1—blood—hepatitis B	0.003	0.0368	CbGeAlD
Triamcinolone—Dyspepsia—Lamivudine—hepatitis B	0.00298	0.0034	CcSEcCtD
Triamcinolone—Fatigue—Lamivudine—hepatitis B	0.00292	0.00333	CcSEcCtD
Triamcinolone—Pain—Lamivudine—hepatitis B	0.00289	0.0033	CcSEcCtD
Triamcinolone—Feeling abnormal—Lamivudine—hepatitis B	0.00279	0.00318	CcSEcCtD
Triamcinolone—Urticaria—Lamivudine—hepatitis B	0.00269	0.00306	CcSEcCtD
Triamcinolone—Body temperature increased—Lamivudine—hepatitis B	0.00267	0.00305	CcSEcCtD
Triamcinolone—BCHE—liver—hepatitis B	0.00264	0.0323	CbGeAlD
Triamcinolone—PTGS2—blood—hepatitis B	0.0026	0.0318	CbGeAlD
Triamcinolone—Hypersensitivity—Lamivudine—hepatitis B	0.00249	0.00284	CcSEcCtD
Triamcinolone—Asthenia—Lamivudine—hepatitis B	0.00243	0.00277	CcSEcCtD
Triamcinolone—Pruritus—Lamivudine—hepatitis B	0.00239	0.00273	CcSEcCtD
Triamcinolone—Prednisolone—CYP2A6—hepatitis B	0.00237	0.349	CrCbGaD
Triamcinolone—NR3C1—liver—hepatitis B	0.00235	0.0288	CbGeAlD
Triamcinolone—CYP3A4—blood—hepatitis B	0.00227	0.0278	CbGeAlD
Triamcinolone—Dizziness—Lamivudine—hepatitis B	0.00224	0.00255	CcSEcCtD
Triamcinolone—Vomiting—Lamivudine—hepatitis B	0.00215	0.00245	CcSEcCtD
Triamcinolone—Rash—Lamivudine—hepatitis B	0.00213	0.00243	CcSEcCtD
Triamcinolone—Dermatitis—Lamivudine—hepatitis B	0.00213	0.00243	CcSEcCtD
Triamcinolone—Headache—Lamivudine—hepatitis B	0.00212	0.00242	CcSEcCtD
Triamcinolone—Dexamethasone—NOS2—hepatitis B	0.00206	0.304	CrCbGaD
Triamcinolone—PTGS2—liver—hepatitis B	0.00203	0.0249	CbGeAlD
Triamcinolone—Nausea—Lamivudine—hepatitis B	0.00201	0.00229	CcSEcCtD
Triamcinolone—CYP3A4—liver—hepatitis B	0.00178	0.0217	CbGeAlD
Triamcinolone—PTGS2—Eicosanoid Synthesis—GGT2—hepatitis B	0.00173	0.0499	CbGpPWpGaD
Triamcinolone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—CYP2A6—hepatitis B	0.00145	0.0418	CbGpPWpGaD
Triamcinolone—Dexamethasone—CYP2A6—hepatitis B	0.00135	0.199	CrCbGaD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00116	0.0335	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptors—HNF4A—hepatitis B	0.00102	0.0294	CbGpPWpGaD
Triamcinolone—Prednisone—ALB—hepatitis B	0.001	0.148	CrCbGaD
Triamcinolone—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.000913	0.0263	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.000908	0.0261	CbGpPWpGaD
Triamcinolone—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.000849	0.0244	CbGpPWpGaD
Triamcinolone—PTGS2—Eicosanoid Synthesis—GGT1—hepatitis B	0.00082	0.0236	CbGpPWpGaD
Triamcinolone—NR3C1—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.000807	0.0232	CbGpPWpGaD
Triamcinolone—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000635	0.0183	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—GGT2—hepatitis B	0.000613	0.0176	CbGpPWpGaD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—hepatitis B	0.000582	0.0167	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—MIF—hepatitis B	0.00057	0.0164	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.000557	0.016	CbGpPWpGaD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—hepatitis B	0.000541	0.0156	CbGpPWpGaD
Triamcinolone—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000531	0.0153	CbGpPWpGaD
Triamcinolone—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000511	0.0147	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—KCNH1—hepatitis B	0.000487	0.014	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MIF—hepatitis B	0.000467	0.0134	CbGpPWpGaD
Triamcinolone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—hepatitis B	0.000458	0.0132	CbGpPWpGaD
Triamcinolone—PTGS2—Arachidonic acid metabolism—GGT1—hepatitis B	0.000456	0.0131	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.000437	0.0126	CbGpPWpGaD
Triamcinolone—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000432	0.0124	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000427	0.0123	CbGpPWpGaD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—hepatitis B	0.000384	0.011	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL10—hepatitis B	0.000379	0.0109	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—hepatitis B	0.000376	0.0108	CbGpPWpGaD
Triamcinolone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000364	0.0105	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—hepatitis B	0.000364	0.0105	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hepatitis B	0.000354	0.0102	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—hepatitis B	0.00035	0.0101	CbGpPWpGaD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—hepatitis B	0.000342	0.00985	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000338	0.00971	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—HLA-A—hepatitis B	0.000334	0.00962	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—TNF—hepatitis B	0.000311	0.00894	CbGpPWpGaD
Triamcinolone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—hepatitis B	0.000304	0.00875	CbGpPWpGaD
Triamcinolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—hepatitis B	0.000294	0.00846	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—GGT1—hepatitis B	0.00029	0.00835	CbGpPWpGaD
Triamcinolone—PTGS2—Overview of nanoparticle effects—IL6—hepatitis B	0.000251	0.00721	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—CDKN2A—hepatitis B	0.000229	0.00658	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IFNG—hepatitis B	0.000223	0.00642	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—hepatitis B	0.000221	0.00637	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CXCL10—hepatitis B	0.000221	0.00635	CbGpPWpGaD
Triamcinolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00022	0.00634	CbGpPWpGaD
Triamcinolone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000218	0.00626	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000213	0.00612	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000209	0.00601	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—FAS—hepatitis B	0.000207	0.00596	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NR0B2—hepatitis B	0.000201	0.00578	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL10—hepatitis B	0.0002	0.00575	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL2—hepatitis B	0.000198	0.0057	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—hepatitis B	0.000198	0.0057	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—hepatitis B	0.000197	0.00566	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—hepatitis B	0.000197	0.00566	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hepatitis B	0.000197	0.00566	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—CTNNB1—hepatitis B	0.000196	0.00564	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—CTNNB1—hepatitis B	0.000191	0.00551	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—PTEN—hepatitis B	0.000187	0.00537	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—F2—hepatitis B	0.000186	0.00535	CbGpPWpGaD
Triamcinolone—BCHE—Peptide hormone metabolism—CTNNB1—hepatitis B	0.00018	0.00519	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000179	0.00514	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—hepatitis B	0.000175	0.00503	CbGpPWpGaD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—hepatitis B	0.000168	0.00483	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000166	0.00479	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hepatitis B	0.000165	0.00474	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—hepatitis B	0.000164	0.00471	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000161	0.00464	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—TGFB1—hepatitis B	0.000158	0.00455	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000157	0.00451	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TGFB1—hepatitis B	0.000155	0.00445	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—ALB—hepatitis B	0.000154	0.00444	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000153	0.00441	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TLR4—hepatitis B	0.000153	0.00439	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CDKN2A—hepatitis B	0.00015	0.00431	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—NOS2—hepatitis B	0.000145	0.00418	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000144	0.00413	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—hepatitis B	0.000143	0.00412	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CD4—hepatitis B	0.000141	0.00406	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IFNG—hepatitis B	0.000141	0.00405	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—HNF4A—hepatitis B	0.000139	0.00401	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TP53—hepatitis B	0.000127	0.00366	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—CDKN1A—hepatitis B	0.000122	0.00352	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.00012	0.00345	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PTEN—hepatitis B	0.000119	0.00343	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000117	0.00337	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—CTNNB1—hepatitis B	0.000117	0.00336	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL6—hepatitis B	0.000117	0.00335	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000115	0.00332	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—CDKN1A—hepatitis B	0.000114	0.00328	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—hepatitis B	0.000112	0.00323	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IFNG—hepatitis B	0.000111	0.0032	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—hepatitis B	0.000103	0.00295	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000101	0.0029	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL2—hepatitis B	9.89e-05	0.00285	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—NFKB1—hepatitis B	9.78e-05	0.00281	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—HSPA5—hepatitis B	9.69e-05	0.00279	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NR0B2—hepatitis B	9.68e-05	0.00279	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	9.49e-05	0.00273	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.47e-05	0.00272	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—hepatitis B	9.42e-05	0.00271	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKR1B1—hepatitis B	9.3e-05	0.00268	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	9.11e-05	0.00262	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GGT2—hepatitis B	8.91e-05	0.00256	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—hepatitis B	8.8e-05	0.00253	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SAG—hepatitis B	8.45e-05	0.00243	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOBEC3G—hepatitis B	8.45e-05	0.00243	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	7.72e-05	0.00222	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—hepatitis B	7.6e-05	0.00219	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—GGT1—hepatitis B	7.41e-05	0.00213	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	7.35e-05	0.00212	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—hepatitis B	7.21e-05	0.00207	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—hepatitis B	7.1e-05	0.00204	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HNF4A—hepatitis B	6.71e-05	0.00193	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	6.52e-05	0.00187	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	6.5e-05	0.00187	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKR1B1—hepatitis B	6.4e-05	0.00184	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TP53—hepatitis B	6.35e-05	0.00183	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	6.35e-05	0.00183	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	6.33e-05	0.00182	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	6.3e-05	0.00181	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—hepatitis B	6.14e-05	0.00177	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GGT2—hepatitis B	6.13e-05	0.00177	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—hepatitis B	5.81e-05	0.00167	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP2A6—hepatitis B	5.4e-05	0.00155	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	5.25e-05	0.00151	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—F2—hepatitis B	5.24e-05	0.00151	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.04e-05	0.00145	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	4.9e-05	0.00141	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GOT2—hepatitis B	4.88e-05	0.00141	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	4.32e-05	0.00124	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GGT1—hepatitis B	4.22e-05	0.00121	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GOT1—hepatitis B	4.22e-05	0.00121	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GOT2—hepatitis B	4.01e-05	0.00115	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.84e-05	0.00111	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2A6—hepatitis B	3.72e-05	0.00107	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.47e-05	0.000997	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GOT1—hepatitis B	3.46e-05	0.000997	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CTNNB1—hepatitis B	3.41e-05	0.00098	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GOT2—hepatitis B	3.36e-05	0.000967	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GGT1—hepatitis B	2.9e-05	0.000835	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GOT1—hepatitis B	2.9e-05	0.000835	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.79e-05	0.000804	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GGT2—hepatitis B	2.68e-05	0.000771	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.64e-05	0.000761	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CCR5—hepatitis B	2.59e-05	0.000744	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HLA-A—hepatitis B	2.52e-05	0.000725	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—hepatitis B	2.24e-05	0.000645	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS2—hepatitis B	2.19e-05	0.000631	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTEN—hepatitis B	1.71e-05	0.000492	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD4—hepatitis B	1.62e-05	0.000467	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.62e-05	0.000467	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—hepatitis B	1.54e-05	0.000444	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GOT2—hepatitis B	1.47e-05	0.000422	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CTNNB1—hepatitis B	1.44e-05	0.000415	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1A—hepatitis B	1.41e-05	0.000406	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTEN—hepatitis B	1.41e-05	0.000405	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GGT1—hepatitis B	1.27e-05	0.000365	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GOT1—hepatitis B	1.27e-05	0.000365	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTEN—hepatitis B	1.18e-05	0.000339	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—hepatitis B	1.17e-05	0.000335	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—hepatitis B	8.78e-06	0.000253	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—hepatitis B	6.74e-06	0.000194	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTEN—hepatitis B	5.14e-06	0.000148	CbGpPWpGaD
